Articles From: FTI Consulting Study Shows that Confidence, not Reputation, is the Primary Driver of Stakeholder Behavior to Navigant’s Continued Investment in Promoting Diversity & Inclusion Leads to Sixth Consecutive Perfect Score on Corporate Equality Index


On Average, Companies Have a 30 Percent Better Chance of Achieving a Desired Behavior if Stakeholders are Confident, than if Stakeholders Say the Company has a Good Reputation WASHINGTON , Nov.
Sign-up for FTI Consulting Study Shows that Confidence, not Reputation, is the Primary Driver of Stakeholder Behavior investment picks
VANCOUVER, British Columbia, Dec.
Sign-up for Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial of AQX-1125 in Atopic Dermatitis investment picks
Enhanced capabilities help B2B clients deploy advanced digital storefronts in minutes with no technical skills or expertise ARMONK, N.Y. , Nov.
Sign-up for IBM Brings Speed and Simplicity to Building Engaging Consumer Experiences for B2B Organizations investment picks
SOUTH SAN FRANCISCO, Calif., Dec.
Sign-up for Calithera Biosciences Gains Exclusive, Worldwide License to Mars Symbioscience's Arginase Inhibitors investment picks
BOTHELL Wash.
Sign-up for OncoGenex to Regain Rights to Custirsen from Teva investment picks
OncoGenex to Regain Rights to Custirsen from Teva Canada NewsWire BOTHELL Wash.
Sign-up for OncoGenex to Regain Rights to Custirsen from Teva investment picks
AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer investment picks
OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer Canada NewsWire AFFINITY Trial to Continue as Planned Following Completion of Interim Futility Analysis BOTHELL, Wash.
Sign-up for OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer investment picks
-- Andexanet Alfa Rapidly Reversed the Anticoagulant Effect of the Factor Xa Inhibitor Eliquis (apixaban) Among All Study Participants --
Sign-up for Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban) investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis (apixaban) by 4-factor prothrombin complex concentrates (PCCs) in healthy subjects.
Sign-up for Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects investment picks
Accelerates RG-101 for HCV with Dual-Track Clinical Development Strategy; Top-Line, Single Dose, 4 mg/kg Results as Well as 2mg/kg Extended Follow Up Results from Ongoing Study to be Reported in Early February 2015 Aims to Advance microRNA Therapeutics Portfolio and Regulus microMarkersSM Division LA JOLLA, Calif.
Sign-up for Regulus Announces Key Goals Under its 'Clinical Map Initiative' for 2015 investment picks
RESEARCH TRIANGLE PARK, N.C., Oct.
Sign-up for BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress investment picks
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema investment picks
RESEARCH TRIANGLE PARK, N.C., Jan.
Sign-up for BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema investment picks
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema investment picks
BURNABY, British Columbia, Jan.
Sign-up for Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015 investment picks
2014/12/4
Discover has once again been named as a Best Place to Work for LGBT Equality on the Human Rights Campaign’s Annual 2015 Corporate Equality Index.
Sign-up for Discover Earns Top Marks on Human Rights Campaign’s Corporate Equality Index investment picks
SEATTLE , Nov.
Sign-up for Alaska Airlines Earns Top Score in 2015 Corporate Equality Index investment picks
WellPoint, Inc. announced today that it received a perfect score of 100 percent on the 2015 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.
Sign-up for WellPoint Earns Designation of ‘Best Place to Work’ for LGBT Equality investment picks
Barnes & Noble, Inc. (NYSE:BKS), the nation’s largest retail bookseller and the leading retailer of content, digital media and educational products, proudly announced that it received a perfect score of 100 percent on the 2015 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.
Sign-up for Barnes & Noble Receives Perfect Score on 2015 Corporate Equality Index for Seventh Straight Year investment picks
DIRECTV, one of the world's leading providers of digital television entertainment services, announced that it received a perfect score of 100 percent on the 2015 Corporate Equality Index (CEI), which is a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation.
Sign-up for DIRECTV Earns Top Marks in 2015 Corporate Equality Index investment picks
John Hancock Earns 100 percent on Human Rights Campaign Foundation's Thirteenth Annual Scorecard on LGBT Workplace Equality BOSTON , Nov.
Sign-up for John Hancock Earns Top Marks in 2015 Corporate Equality Index investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026771-001&sourceType=1 NEW YORK, NY--(Marketwired - November 19, 2014) - JetBlue Airways Corporation, New York's Hometown Airline, is proud to announce that it has earned the top score of 100 percent on the 2015 Corporate Equality Index (CEI), a leading survey and report on corporate policies and practices related to LGBT workplace equality from the Human Rights Campaign Foundation.
Sign-up for JetBlue Earns Perfect Score in Human Rights Campaign's 2015 Corporate Equality Index investment picks
Global professional services company Towers Watson (NYSE, NASDAQ: TW) today announced it received a perfect score of 100% for the 2015 Corporate Equality Index, a national benchmarking survey and report on corporate policies and practices pertinent to lesbian, gay, bisexual and transgender (LGBT) employees.
Sign-up for Towers Watson Earns Top Marks for LGBT Workplace Equality investment picks
The Hartford has been recognized as a Best Place to Work for Lesbian, Gay, Bisexual and Transgender (LGBT) Equality by the Human Rights Campaign (HRC). The company received the accolade for scoring 100 percent on the HRC's 2015 Corporate Equality Index (CEI). "The Hartford is honored to be recognized once again as a top employer for the LGBT community,” said Susan Johnson, vice president of diversity and inclusion at The Hartford.
Sign-up for The Hartford Named A Best Place To Work For LGBT Equality For Seventh Year investment picks
MUFG Union Bank, N.A ., announced today that it has earned a perfect score of 100 percent on the Human Rights Campaign’s (HRC) 2015 Corporate Equality Index (CEI). This is the second year that MUFG Union Bank has participated and received a perfect score in HRC’s rating system, which serves as the national benchmarking tool for corporate policies and practices related to lesbian, gay, bisexual, and transgender (LGBT) employees.
Sign-up for MUFG Union Bank Earns 100 Percent Score on Human Rights Campaign’s 2015 Corporate Equality Index investment picks
Today Navigant (NYSE: NCI) announced its sixth consecutive perfect score on Human Rights Campaign Foundation’s annual scorecard for Lesbian, Gay, Bisexual and Transgender (LGBT) equality.
Sign-up for Navigant’s Continued Investment in Promoting Diversity & Inclusion Leads to Sixth Consecutive Perfect Score on Corporate Equality Index investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: FTI Consulting Study Shows that Confidence, not Reputation, is the Primary Driver of Stakeholder Behavior to Navigant’s Continued Investment in Promoting Diversity & Inclusion Leads to Sixth Consecutive Perfect Score on Corporate Equality Index
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent